Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital
For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.
Rewriting The Code: Advances And Challenges In Pediatric Gene Therapy
This presentation examines pediatric gene therapy and the three platforms now driving clinical progress: AAV vectors, lentiviral vectors, and CRISPR-based gene editing.
The Implications Of Semaglutide's Connect To Increased Risk Of NAION
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors
Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

Redefining Accessibility For Pediatric Patients
9/24/2025

Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.
Supporting Participants Through National Travel Disruptions
12/10/2025

A sudden travel shutdown threatened a critical clinical visit. Rapid rescheduling, coordinated logistics, and clear communication ensured engagement and the ability to continue without interruption.
Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views
9/23/2025

Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.
Scaling Outsourced Clinical Trial Services
6/16/2026

Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.
Tips And Tricks For Developing Rare Cancer Clinical Trials
2/6/2025

Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.

Eliminate Review Friction With An Industry-First IRB Platform

Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
Driving Successful In CNS And Neurology Trials

Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate.
Think Bold. Think Scientific. Think Veristat.

Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
Special And Patient Populations

Altasciences has the advanced level of clinical expertise required to successfully recruit and conduct clinical trials involving special and patient populations.
Integrating Lyft Pass To Increase Flexibility For Trial Participants

Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.